Merck

MERCK NEWSROOM (5 press releases)

Advanced Filtering & Sorting Options:

Merck Celebrates SPARK Anniversary as Employee Volunteer Initiative Reaches Hundreds of Thousands of Students Worldwide

PRESS RELEASE -- 19, March 2026

(IN BRIEF) Merck is marking the 10th anniversary of its SPARK™ employee volunteer program, which has grown into a global initiative focused on promoting science education and community engagement. Since 2016, the program has mobilized employees across 48 countries to … Read the full press release

AstraZeneca’s Imfinzi Regimen Approved in the European Union for Early-Stage Gastric and Gastroesophageal Junction Cancers

PRESS RELEASE -- 16, March 2026

(IN BRIEF) AstraZeneca has received approval from the European Commission for the use of Imfinzi (durvalumab) in combination with FLOT chemotherapy as a perioperative treatment for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers. The approval … Read the full press release

Michael Otto’s Entrepreneurial Legacy and Sustainable Vision Shape Otto Group Ahead of Leadership Transition

PRESS RELEASE -- 24, February 2026

(IN BRIEF) Prof. Dr. Michael Otto will hand over primary responsibility for the Otto Group to his son Benjamin Otto on 1 March, concluding more than five decades of leadership that transformed the family-founded Otto-Versand into a global digital retail … Read the full press release

TotalEnergies and Airbus Sign Long-Term Renewable Power Contracts Covering Half of Key Sites’ Electricity Demand

PRESS RELEASE -- 5, February 2026

(IN BRIEF) TotalEnergies and Airbus have signed two clean firm power agreements that will supply 3.3 TWh of baseload renewable electricity per year to Airbus’ major sites in Germany and the United Kingdom from 2027 onward, covering about half of … Read the full press release

Basilea Expands Anti-Infective Pipeline Through Antifungal Collaboration with Prokaryotics

PRESS RELEASE -- 7, January 2026

(IN BRIEF) Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The partnership focuses on novel compounds with a new mode of action aimed at pathogens such … Read the full press release